Therefore, it is speculated that MTHFD1L might up-regulate in BLCA, HNSC, KIRP, LUAD, and UCEC patients regardless of heterogeneity-barrier. This evidence concerns the gene MTHFD1L and bladder transitional cell carcinoma.